By combining databases, the m5C prediction website, and the MeRIP-qPCR assay, Zhao et al. revealed for the first time that NSUN4, as a key writer for controlling m5C levels in glioma, mediates changes in m5C levels to promote the stability of CDC42 mRNA. This evidence concerns the gene NSUN4 and central nervous system cancer.